Heidelberg Pharma investor relations material

Listen to the latest call from Heidelberg Pharma

Heidelberg Pharma is a biopharmaceutical company that focuses on oncology and antibody targeted amanitin conjugates (ATAC). Their innovations are based on cell immunotherapy and the drug amanitin conjugates (ATAC). The tumor cells are attacked by immune cells, which recognize the amanitin antigen as a foreign body. This way the treatment causes no mutilation of healthy tissue.

  • Ticker

  • Country


Dig deeper into the Heidelberg Pharma fundamentals on Quartr.